HIV infections among adolescents and young adults continue to be at high levels, with Americans between the ages of 13 and 24 accounting for approximately 20% of all new HIV infections in 2019.

Please provide your email address to receive an email when new articles are posted on . PrEP coverage in the U.S. between 2012-2021 ranged from 3.8% in West Virginia to 22.2% in New York. Australian ...

Pre-exposure prophylaxis, known as PrEP, is dramatically effective at preventing HIV infections. When taken correctly, the pill can reduce the risk of contracting HIV through drug injection by up to ...

The HIV epidemic remains a critical public health priority in the United States. The Ending the HIV Epidemic (EHE) initiative seeks to reduce HIV diagnoses by 75% by 2025 and by 90% by 2030. Certain ...

A brand new drug might be more effective at preventing HIV than current methods. Many people take daily oral antiretroviral medication—known as PrEP (pre-exposure prophylaxis)—to protect themselves ...

By a News Reporter-Staff News Editor at CDC& FDA Daily-- Current study results on health insurance have been published. Our news reporters obtained a quote from the research from National Center for ...

Residents grew more knowledgeable and more comfortable with using pre-exposure prophylaxis (PrEP) drugs for prevention against HIV after training was included in their residency program. PrEP is ...

Credit: Gilead. Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen. Yeztugo demonstrated superiority over Truvada in reducing the ...

HIV preexposure prophylaxis (PrEP) is highly effective at preventing HIV acquisition, a study has confirmed. Research led by the UK Health Security Agency (UKHSA) and Chelsea and Westminster Hospital ...

HIV (Human Immunodeficiency Virus) is the virus that can lead to acquired immunodeficiency syndrome or AIDS if not treated. Unlike some other viruses, the human body can’t get rid of HIV completely, ...